-
April 12, 2021
Sydney Researchers Identify/Advance Potential Revolutionary New Drug Treatment for Fatal Childhood CancerBookmark
George Lundberg, MDA press release from the Children’s Cancer Institute outlines hopeful results from experiments performed in mice and 3-D computer models that investigated a new treatment for the rare childhood brain tumor diffuse intrinsic pontine glioma (DIPG). The treatment consists of a combination of the drugs difluoromethylornithine (DFMO) and AMXT 1501. This combo is already being tested in clinical trials in adults with cancer, and will soon be tested in children with DIPG.
.
-
April 12, 2021
Chemo for Glioblastoma May Work Better in Morning Than EveningBookmark
George Lundberg, MDA press release from ScienceDaily outlines results from a small study of patients receiving a standard, FDA-approved treatment (temozolomide) for glioblastoma. The results suggest that some patients may survive a few months longer, all because of time of day for administering the drug.
.
-
April 12, 2021
FDA Approves New Treatment For Adults With Relapsed Or Refractory Large-B-Cell LymphomaBookmark
George Lundberg, MDThe U.S. Food and Drug Administration (FDA) has approved a cell-based gene therapy known as lisocabtagene maraleucel (brand name Breyanzi) for relapsed or refractory large B-cell lymphoma.
.
-
April 12, 2021
Nivolumab: First Adjuvant Immunotherapy to Show Survival Benefit in High-Risk Muscle-Invasive Urothelial CancerBookmark
George Lundberg, MDThe ASCO Post reports new results from a clinical trial in which the drug nivolumab (Opdivo) nearly doubled progression-free survival compared to a placebo drug for people with muscle-invasive bladder cancer.
.
-
April 12, 2021
FDA Grants Full Approval to Sacituzumab Govitecan for Triple-Negative Breast CancerBookmark
George Lundberg, MDRecurrent triple-negative breast cancer is particularly difficult to treat. As reported by Cancer Network, the U.S. Food and Drug Administration (FDA) has now approved the drug sacituzumab govitecan (Trodelvy) for treating people with this disease, depending on their stage and treatment history.
.
-
April 12, 2021
Lenvatinib/Pembrolizumab Improves Survival in Advanced Endometrial CancerBookmark
George Lundberg, MDThe ASCO Post reports on new results from a clinical trial testing a combination of the drugs lenvatinib and pembrolizumab in people with advanced or recurrent endometrial cancer. The results show that, compared to standard chemotherapy, this drug combo improves both overall and progression-free survival—according to both statistical and clinical analysis.
.
-
March 9, 2021
Just Diagnosed with Advanced Lung Cancer: What Now?
With:A new cancer diagnosis is overwhelming. Patients often ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks lung cancer expert Howard (Jack) West, MD, how he would handle his own diagnosis of advanced lung cancer. Dr. West is a Princeton- and Harvard-educated oncologist with additional training and experience in Boston and Seattle focusing on lung cancer.… Read more »
-
February 20, 2021
Treatment of Stage IV- Metastatic or Recurrent Colon CancerBookmark
George Lundberg, MDThis CancerConnect article summarizes the latest treatment options for stage IV colorectal cancer.
.
-
February 2, 2021
How an Expert Would Manage Her Own Advanced Ovarian Cancer
With:Cancer patients often ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks oncologist Summer Dewdney, MD, how she would handle her own diagnosis of advanced ovarian cancer. Dr. Dewdney is Director of the Division of Gynecologic Oncology at Rush University Medical Center in Chicago, Illinois. Curious Dr. George: You are an expert clinical oncologist treating patients… Read more »
-
December 18, 2020
How an Expert Would Manage Her Own Advanced Colorectal Cancer
With:When facing a new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks Cancer Commons Expert Physician Advisor Christina Wu, MD, how she would handle her own diagnosis of metastatic colorectal cancer. Dr. Wu is Associate Professor of Hematology/Oncology and Associate Division Director of Medical Oncology at Winship Cancer Institute of Emory… Read more »